China NMPA Product Recall - Mosaic Porcine Bioprosthesis (a porcine bioprosthetic valve) and Hancock II Porcine Bioprosthesis (an artificial heart valve)

Medtronic Inc., a medical device manufacturer, initiated a voluntary Class III recall for two of its bioprosthetic products: the Mosaic Porcine Bioprosthesis and the Hancock II Porcine Bioprosthesis. This action, reported by Medtronic (Shanghai) Management Co., Ltd. and publicly announced on June 21, 2019, was conducted under the regulatory oversight of the National Medical Products Administration (NMPA). The main violation identified was a discrepancy between the packaging label size and the actual product dimensions. This labeling inconsistency, while not indicating a direct product performance or safety defect, necessitated immediate corrective action to prevent potential confusion in clinical settings. A Class III recall designation signifies that the issue is unlikely to cause adverse health consequences. The required action involved Medtronic Inc. undertaking a voluntary recall of the affected products to rectify the labeling variance and ensure full compliance with established product identification and packaging standards, reflecting a commitment to regulatory adherence and patient safety within the medical device industry.